Global PET Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 83524
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The PET Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global PET Radiopharmaceuticals size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global PET Radiopharmaceuticals market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

PET Radiopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

F-18

Ru-82

Others

Market segment by Application can be divided into

Oncology

Cardiology

Neurology

Others

The key market players for global PET Radiopharmaceuticals market are listed below:

Cardinal Health Inc. (U.S.)

Mallinckrodt plc (Ireland)

GE Healthcare (U.K.)

Lantheus Medical Imaging, Inc. (U.S.)

Bayer AG (Germany)

Bracco Imaging S.p.A (Italy)

Eczacibasi-Monrol Nuclear Products (Turkey)

Nordion, Inc. (Canada)

Advanced Accelerator Applications S.A. (France)

IBA Molecular Imaging (Belgium)

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe PET Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of PET Radiopharmaceuticals, with price, sales, revenue and global market share of PET Radiopharmaceuticals from 2019 to 2021.

Chapter 3, the PET Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the PET Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and PET Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe PET Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 PET Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global PET Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 F-18

1.2.3 Ru-82

1.2.4 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global PET Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Neurology

1.3.5 Others

1.4 Global PET Radiopharmaceuticals Market Size & Forecast

1.4.1 Global PET Radiopharmaceuticals Sales in Value (2016-2026))

1.4.2 Global PET Radiopharmaceuticals Sales in Volume (2016-2026)

1.4.3 Global PET Radiopharmaceuticals Price by Type (2016-2026) & (USD/Pcs)

1.5 Global PET Radiopharmaceuticals Production Capacity Analysis

1.5.1 Global PET Radiopharmaceuticals Total Production Capacity (2016-2026)

1.5.2 Global PET Radiopharmaceuticals Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 PET Radiopharmaceuticals Market Drivers

1.6.2 PET Radiopharmaceuticals Market Restraints

1.6.3 PET Radiopharmaceuticals Trends Analysis

2 Manufacturers Profiles

2.1 Cardinal Health Inc. (U.S.)

2.1.1 Cardinal Health Inc. (U.S.) Details

2.1.2 Cardinal Health Inc. (U.S.) Major Business

2.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services

2.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Mallinckrodt plc (Ireland)

2.2.1 Mallinckrodt plc (Ireland) Details

2.2.2 Mallinckrodt plc (Ireland) Major Business

2.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services

2.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 GE Healthcare (U.K.)

2.3.1 GE Healthcare (U.K.) Details

2.3.2 GE Healthcare (U.K.) Major Business

2.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services

2.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Lantheus Medical Imaging, Inc. (U.S.)

2.4.1 Lantheus Medical Imaging, Inc. (U.S.) Details

2.4.2 Lantheus Medical Imaging, Inc. (U.S.) Major Business

2.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services

2.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Bayer AG (Germany)

2.5.1 Bayer AG (Germany) Details

2.5.2 Bayer AG (Germany) Major Business

2.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Product and Services

2.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Bracco Imaging S.p.A (Italy)

2.6.1 Bracco Imaging S.p.A (Italy) Details

2.6.2 Bracco Imaging S.p.A (Italy) Major Business

2.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services

2.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Eczacibasi-Monrol Nuclear Products (Turkey)

2.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Details

2.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Major Business

2.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services

2.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Nordion, Inc. (Canada)

2.8.1 Nordion, Inc. (Canada) Details

2.8.2 Nordion, Inc. (Canada) Major Business

2.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services

2.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Advanced Accelerator Applications S.A. (France)

2.9.1 Advanced Accelerator Applications S.A. (France) Details

2.9.2 Advanced Accelerator Applications S.A. (France) Major Business

2.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services

2.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 IBA Molecular Imaging (Belgium)

2.10.1 IBA Molecular Imaging (Belgium) Details

2.10.2 IBA Molecular Imaging (Belgium) Major Business

2.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services

2.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 PET Radiopharmaceuticals Sales by Manufacturer

3.1 Global PET Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)

3.2 Global PET Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in PET Radiopharmaceuticals

3.4 Market Concentration Rate

3.4.1 Top 3 PET Radiopharmaceuticals Manufacturer Market Share

3.4.2 Top 6 PET Radiopharmaceuticals Manufacturer Market Share

3.5 Global PET Radiopharmaceuticals Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and PET Radiopharmaceuticals Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global PET Radiopharmaceuticals Market Size by Region

4.1.1 Global PET Radiopharmaceuticals Sales in Volume by Region (2016-2026)

4.1.2 Global PET Radiopharmaceuticals Revenue by Region (2016-2026)

4.2 North America PET Radiopharmaceuticals Revenue (2016-2026)

4.3 Europe PET Radiopharmaceuticals Revenue (2016-2026)

4.4 Asia-Pacific PET Radiopharmaceuticals Revenue (2016-2026)

4.5 South America PET Radiopharmaceuticals Revenue (2016-2026)

4.6 Middle East and Africa PET Radiopharmaceuticals Revenue (2016-2026)

5 Market Segment by Type

5.1 Global PET Radiopharmaceuticals Sales in Volume by Type (2016-2026)

5.2 Global PET Radiopharmaceuticals Revenue by Type (2016-2026)

5.3 Global PET Radiopharmaceuticals Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global PET Radiopharmaceuticals Sales in Volume by Application (2016-2026)

6.2 Global PET Radiopharmaceuticals Revenue by Application (2016-2026)

6.3 Global PET Radiopharmaceuticals Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America PET Radiopharmaceuticals Sales by Type (2016-2026)

7.2 North America PET Radiopharmaceuticals Sales by Application (2016-2026)

7.3 North America PET Radiopharmaceuticals Market Size by Country

7.3.1 North America PET Radiopharmaceuticals Sales in Volume by Country (2016-2026)

7.3.2 North America PET Radiopharmaceuticals Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe PET Radiopharmaceuticals Sales by Type (2016-2026)

8.2 Europe PET Radiopharmaceuticals Sales by Application (2016-2026)

8.3 Europe PET Radiopharmaceuticals Market Size by Country

8.3.1 Europe PET Radiopharmaceuticals Sales in Volume by Country (2016-2026)

8.3.2 Europe PET Radiopharmaceuticals Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific PET Radiopharmaceuticals Sales by Type (2016-2026)

9.2 Asia-Pacific PET Radiopharmaceuticals Sales by Application (2016-2026)

9.3 Asia-Pacific PET Radiopharmaceuticals Market Size by Region

9.3.1 Asia-Pacific PET Radiopharmaceuticals Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific PET Radiopharmaceuticals Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America PET Radiopharmaceuticals Sales by Type (2016-2026)

10.2 South America PET Radiopharmaceuticals Sales by Application (2016-2026)

10.3 South America PET Radiopharmaceuticals Market Size by Country

10.3.1 South America PET Radiopharmaceuticals Sales in Volume by Country (2016-2026)

10.3.2 South America PET Radiopharmaceuticals Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa PET Radiopharmaceuticals Sales by Type (2016-2026)

11.2 Middle East & Africa PET Radiopharmaceuticals Sales by Application (2016-2026)

11.3 Middle East & Africa PET Radiopharmaceuticals Market Size by Country

11.3.1 Middle East & Africa PET Radiopharmaceuticals Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 PET Radiopharmaceuticals Typical Distributors

12.3 PET Radiopharmaceuticals Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global PET Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026

Table 2. Global PET Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026

Table 3. Cardinal Health Inc. (U.S.) Basic Information, Manufacturing Base and Competitors

Table 4. Cardinal Health Inc. (U.S.) Major Business

Table 5. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services

Table 6. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Mallinckrodt plc (Ireland) Basic Information, Manufacturing Base and Competitors

Table 8. Mallinckrodt plc (Ireland) Major Business

Table 9. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services

Table 10. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. GE Healthcare (U.K.) Basic Information, Manufacturing Base and Competitors

Table 12. GE Healthcare (U.K.) Major Business

Table 13. GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services

Table 14. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors

Table 16. Lantheus Medical Imaging, Inc. (U.S.) Major Business

Table 17. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services

Table 18. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Bayer AG (Germany) Basic Information, Manufacturing Base and Competitors

Table 20. Bayer AG (Germany) Major Business

Table 21. Bayer AG (Germany) PET Radiopharmaceuticals Product and Services

Table 22. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base and Competitors

Table 24. Bracco Imaging S.p.A (Italy) Major Business

Table 25. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services

Table 26. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Manufacturing Base and Competitors

Table 28. Eczacibasi-Monrol Nuclear Products (Turkey) Major Business

Table 29. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services

Table 30. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Nordion, Inc. (Canada) Basic Information, Manufacturing Base and Competitors

Table 32. Nordion, Inc. (Canada) Major Business

Table 33. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services

Table 34. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Advanced Accelerator Applications S.A. (France) Basic Information, Manufacturing Base and Competitors

Table 36. Advanced Accelerator Applications S.A. (France) Major Business

Table 37. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services

Table 38. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. IBA Molecular Imaging (Belgium) Basic Information, Manufacturing Base and Competitors

Table 40. IBA Molecular Imaging (Belgium) Major Business

Table 41. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services

Table 42. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Global PET Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Pcs)

Table 44. Global PET Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 45. Market Position of Manufacturers in PET Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 46. Global PET Radiopharmaceuticals Production Capacity by Company, (K Pcs): 2020 VS 2021

Table 47. Head Office and PET Radiopharmaceuticals Production Site of Key Manufacturer

Table 48. PET Radiopharmaceuticals New Entrant and Capacity Expansion Plans

Table 49. PET Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years

Table 50. Global PET Radiopharmaceuticals Sales by Region (2016-2021e) & (K Pcs)

Table 51. Global PET Radiopharmaceuticals Sales by Region (2021-2026) & (K Pcs)

Table 52. Global PET Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 53. Global PET Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 54. Global PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 55. Global PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 56. Global PET Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)

Table 57. Global PET Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)

Table 58. Global PET Radiopharmaceuticals Price by Type (2016-2021e) & (USD/Pcs)

Table 59. Global PET Radiopharmaceuticals Price by Type (2021-2026) & (USD/Pcs)

Table 60. Global PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 61. Global PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 62. Global PET Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)

Table 63. Global PET Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)

Table 64. Global PET Radiopharmaceuticals Price by Application (2016-2021e) & (USD/Pcs)

Table 65. Global PET Radiopharmaceuticals Price by Application (2021-2026) & (USD/Pcs)

Table 66. North America PET Radiopharmaceuticals Sales by Country (2016-2021e) & (K Pcs)

Table 67. North America PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Pcs)

Table 68. North America PET Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 69. North America PET Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 70. North America PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 71. North America PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 72. North America PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 73. North America PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 74. Europe PET Radiopharmaceuticals Sales by Country (2016-2021e) & (K Pcs)

Table 75. Europe PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Pcs)

Table 76. Europe PET Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 77. Europe PET Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 78. Europe PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 79. Europe PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 80. Europe PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 81. Europe PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 82. Asia-Pacific PET Radiopharmaceuticals Sales by Region (2016-2021e) & (K Pcs)

Table 83. Asia-Pacific PET Radiopharmaceuticals Sales by Region (2021-2026) & (K Pcs)

Table 84. Asia-Pacific PET Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 85. Asia-Pacific PET Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 86. Asia-Pacific PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 87. Asia-Pacific PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 88. Asia-Pacific PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 89. Asia-Pacific PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 90. South America PET Radiopharmaceuticals Sales by Country (2016-2021e) & (K Pcs)

Table 91. South America PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Pcs)

Table 92. South America PET Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 93. South America PET Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 94. South America PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 95. South America PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 96. South America PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 97. South America PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 98. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2016-2021e) & (K Pcs)

Table 99. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Pcs)

Table 100. Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 101. Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 102. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2016-2021e) & (K Pcs)

Table 103. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Pcs)

Table 104. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2016-2021e) & (K Pcs)

Table 105. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Pcs)

Table 106. Direct Channel Pros & Cons

Table 107. Indirect Channel Pros & Cons

Table 108. PET Radiopharmaceuticals Typical Distributors

Table 109. PET Radiopharmaceuticals Typical Customers

List of Figures

Figure 1. PET Radiopharmaceuticals Picture

Figure 2. Global PET Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 3. F-18

Figure 4. Ru-82

Figure 5. Others

Figure 6. Global PET Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 7. Oncology

Figure 8. Cardiology

Figure 9. Neurology

Figure 10. Others

Figure 11. Global PET Radiopharmaceuticals Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026

Figure 12. Global PET Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)

Figure 13. Global PET Radiopharmaceuticals Sales (2016-2026) & (K Pcs)

Figure 14. Global PET Radiopharmaceuticals Price by Type (2016-2026) & (USD/Pcs)

Figure 15. Global PET Radiopharmaceuticals Production Capacity (2016-2026) & (K Pcs)

Figure 16. Global PET Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021

Figure 17. PET Radiopharmaceuticals Market Drivers

Figure 18. PET Radiopharmaceuticals Market Restraints

Figure 19. PET Radiopharmaceuticals Market Trends

Figure 20. Global PET Radiopharmaceuticals Sales Market Share by Manufacturer in 2020

Figure 21. Global PET Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020

Figure 22. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. Top 3 PET Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 24. Top 6 PET Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 25. Global PET Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 26. Global PET Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 27. North America PET Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 28. Europe PET Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 29. Asia-Pacific PET Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 30. South America PET Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 31. Middle East & Africa PET Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 32. Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 33. Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2026)

Figure 34. Global PET Radiopharmaceuticals Price by Type (2016-2026) & (USD/Pcs)

Figure 35. Global PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 36. Global PET Radiopharmaceuticals Revenue Market Share by Application (2016-2026)

Figure 37. Global PET Radiopharmaceuticals Price by Application (2016-2026) & (USD/Pcs)

Figure 38. North America PET Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 39. North America PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 40. North America PET Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 41. North America PET Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 42. United States PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe PET Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 46. Europe PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 47. Europe PET Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 48. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 49. Germany PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific PET Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 58. China PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Korea PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America PET Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 65. South America PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 66. South America PET Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 67. South America PET Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 68. Brazil PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 71. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 72. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 73. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 74. Turkey PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Egypt PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Africa PET Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz